Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Study of Neural Circuit Responses to COMT Inhibitors
Conditions
Interventions
Tolcapone
Placebo
Locations
2
United States
University of California, Berkeley
Berkeley, California, United States
UCSF: Ernest Gallo Clinic and Research Center
Emeryville, California, United States
Start Date
March 1, 2010
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2018
Last Updated
November 20, 2020
NCT05894980
NCT04785677
NCT02595164
NCT01805401
NCT01378923
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions